Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 237 is a genomically encoded, non-functional copy of the 5S ribosomal RNA (rRNA) gene, classified as a processed or duplicated pseudogene[4]. 5S rRNA genes encode a 120 nucleotide non-coding RNA essential for ribosome structure and function; however, RNA5SP237 does not produce a functional 5S rRNA transcript and does not contribute to ribosome assembly[1][3][4]. Pseudogenes like RNA5SP237 typically arise from duplication or retrotransposition events followed by loss of coding or regulatory function, and many have no cellular function[4]. In large-scale transcriptome studies, pseudogene expression profiles, including some 5S rRNA pseudogenes, have been linked to cancer subtype classification and prognosis, though there is no evidence specifically implicating RNA5SP237 as a therapeutic target, biomarker, or disease gene on its own[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 237 (RNA5SP237).